A case report of immune-mediated arthritis in a patient with cutaneous melanoma receiving checkpoint inhibition therapy

INTRODUCTION: Immune checkpoint inhibitors (ICIs) represent an important advance in the treatment of melanoma. ICIs may induce autoimmune phenomena caused by concurrent activation of the immune system against normal cells. During the last years, cases of musculoskeletal side effects, especially immu...

Descripción completa

Detalles Bibliográficos
Autores principales: Papaxoinis, George, Anastasopoulou, Amalia, Laskari, Katerina, Diamantopoulos, Panagiotis, Benopoulou, Olga, Gogas, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478575/
https://www.ncbi.nlm.nih.gov/pubmed/32150095
http://dx.doi.org/10.1097/MD.0000000000019439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7478575/
https://www.ncbi.nlm.nih.gov/pubmed/32150095
http://dx.doi.org/10.1097/MD.0000000000019439

Ejemplares similares